Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
Cell & Gene Therapy
Biotech
Flagship-founded Tessera plans to lay off 90 employees in March
Starting March 8, the mass layoff will affect employees based in several U.S. states.
James Waldron
Jan 8, 2026 10:00am
UK biotech eyes $1B deal to deliver eye gene therapy at doctor
Jan 6, 2026 6:25am
Fierce Biotech's 10 most-read stories of 2025
Dec 29, 2025 7:00am
Hope springs toward Parkinson's phase 3 despite divergent data
Dec 23, 2025 9:00am
Fierce's favorite research stories of 2025
Dec 23, 2025 5:00am
Fierce Biotech's 2025 must-reads
Dec 19, 2025 7:00am
